Catalent, Inc. to Present at November 2020 Virtual Investor Conferences

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Tags

conferences

Rhea-AI Summary

Catalent, Inc. (NYSE: CTLT) announced that its executive leadership team will present at two virtual investor conferences. The first is on November 16, 2020, at 10:00 a.m. ET for the Stephens Annual Investment Conference, followed by the Jefferies London Healthcare Conference on November 17, 2020, at 10:50 a.m. ET. Both presentations will be available via live webcast at investor.catalent.com with replays accessible post-event. Catalent is a global leader in advanced delivery technologies and generated over $3 billion in revenue in FY 2020.

11/11/2020 - 09:16 AM

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that members of its executive leadership team will present at two upcoming virtual investor conferences.

On November 16, 2020 at 10:00 a.m. ET, the Company will present at the Stephens Annual Investment Conference. On November 17, 2020 at 10:50 a.m. ET, the Company will present at the Jefferies London Healthcare Conference.

A live webcast of both presentations will be accessible at http://investor.catalent.com and will be available for replay following the event.

About Catalent, Inc.

Catalent, Inc. (NYSE: CTLT), an S&P 500^® company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs more than 14,000 people, including approximately 2,400 scientists, at more than 40 facilities across four continents and in fiscal 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, please visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

Contacts

Investors:
Paul Surdez, Catalent, Inc.
(732) 537-6325
investors@catalent.com

FAQ

When will Catalent present at the Stephens Annual Investment Conference?

Catalent will present at the Stephens Annual Investment Conference on November 16, 2020, at 10:00 a.m. ET.

What is the date and time for Catalent's presentation at the Jefferies London Healthcare Conference?

Catalent will present at the Jefferies London Healthcare Conference on November 17, 2020, at 10:50 a.m. ET.

How can I access the live webcast of Catalent's presentations?

The live webcast of Catalent's presentations can be accessed at investor.catalent.com.

What revenue did Catalent generate in fiscal year 2020?

Catalent generated over $3 billion in revenue in fiscal year 2020.

What does Catalent specialize in?

Catalent specializes in advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products.